{
    "Orphapacket": {
        "ORPHApacketId": "99918",
        "creationDate": "2022-11-28 11:04:13",
        "version": "1.3.18 / 4.1.7 [2022-07-12] (orientdb version)",
        "copyright": "Orphanet (c) 2022",
        "ORPHAcode": "99918",
        "Label": "Streptococcal toxic-shock syndrome",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_99918",
        "DisorderType": {
            "value": "Etiological subtype",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377795"
        },
        "Synonyms": [
            {
                "Synonym": "Streptococcal TSS"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "Streptococcal toxic-shock syndrome (streptococcal TSS) is an acute disease mediated by the production of superantigenic toxins characterized by the sudden onset of fever and other febrile symptoms pain multisystem organ involvement and potentially leading to coma shock and death due to a <i>Streptococcus pyogenes</i> infection."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "36234",
                        "Label": "Bacterial toxic-shock syndrome"
                    }
                ]
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "21976764[PMID]_Dr Lina G\u00e9rard[EXPERT]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "France"
                }
            },
            {
                "Prevalence": {
                    "Source": "22534148[PMID]_Dr Lina G\u00e9rard[EXPERT]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "United States"
                }
            },
            {
                "Prevalence": {
                    "Source": "17638193[PMID]_Dr Lina G\u00e9rard[EXPERT]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Sweden"
                }
            },
            {
                "Prevalence": {
                    "Source": "15815000[PMID]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Denmark"
                }
            }
        ],
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "All ages"
                }
            ]
        },
        "AverageAgeOfDeaths": {
            "AverageAgeOfDeath": [
                {
                    "value": "any age"
                }
            ]
        },
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Not applicable"
                }
            ]
        }
    }
}